In China, vaccine hesitancy lingers even as COVID cases surge

Autopsies indicated SAR-COV-2 spread throught the body and lingered.

COVID booster prompts good immune response, except after recent infection --study

A study today in Clinical Infectious Diseases finds that a third COVID-19 vaccine dose triggered a robust immune response, regardless of whether recipients had been infected more than 3 months earlier, but it didn't significantly increase antibody levels in those infected less than 3 months before.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

U.S. COVID winter hospitalizations expected to surpass this summer's peak

Omicron offshoot XBB.1.5 could drive new Covid-19 surge in US

China, EU in dispute over China's COVID crisis, Beijing threatens countermeasures

COVID in 2023 and beyond—why virus trends are more difficult to predict three years on

COVID variant XBB.1.5 now accounts for 40 percent of cases in the US: CDC

Lack of info on China’s COVID-19 surge stirs global concern

WHO urges China to share specific data regularly on COVID situation

WHO urges China to share specific data regularly on COVID situation

3 things to watch in chronic disease in 2023: obesity drugs, long Covid and health care costs

Flu and RSV on the decline but Covid hospitalizations rise

It's Getting Tougher to Afford Health Care, Even With Employer-Sponsored Insurance

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

A promising new Covid pill shows key advantages over Paxlovid in trial

...

"You have a medication that looks to be just as good as Paxlovid, but less cumbersome," said Dr. Panagis Galiatsatos, an assistant professor of medicine at Johns Hopkins Medicine in Baltimore.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Global RSS
howdy folks